Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Loading...
Community
/
United States
/
Healthcare
/
IDEXX Laboratories
Create a narrative
IDEXX Laboratories Community
NasdaqGS:IDXX Community
3
Narratives
written by author
0
Comments
on narratives written by author
46
Fair Values set
on narratives written by author
Community Investing Ideas
IDEXX Laboratories
Popular
Undervalued
Overvalued
IDEXX Laboratories
AN
AnalystHighTarget
Community Contributor
Global Pet Ownership And AI Diagnostics Will Expand Market Opportunities
Key Takeaways Strong adoption of innovative diagnostics and software ecosystem is accelerating recurring revenue growth, margin expansion, and customer retention beyond expectations. International growth and industry leadership in AI-enabled preventive care position the company to substantially expand its addressable market and gain operating leverage.
View narrative
US$785
FV
19.5% undervalued
intrinsic discount
9.65%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
1
users have followed this narrative
17 days ago
author updated this narrative
IDEXX Laboratories
AN
AnalystConsensusTarget
Based on Analyst Price Targets
Advanced Diagnostics And International Expansion Will Define Future Opportunity
Key Takeaways Expansion in innovative diagnostic platforms and international markets is driving recurring revenue growth, margin expansion, and enhanced geographic diversification. Strong customer retention and broader adoption of cloud solutions create stable, high-margin revenue streams and position the company for sustained long-term earnings growth.
View narrative
US$695.09
FV
9.0% undervalued
intrinsic discount
8.81%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
18
users have followed this narrative
17 days ago
author updated this narrative
IDEXX Laboratories
AN
AnalystLowTarget
Community Contributor
Declining Pet Ownership And Rising Compliance Costs Will Erode Margins
Key Takeaways Demographic shifts and economic pressures are shrinking the addressable market, suppressing demand for premium diagnostics, and limiting revenue and margin growth. Rising competition, market saturation, and regulatory hurdles could erode pricing power, slow recurring sales, and increase costs, challenging the company's profitable growth model.
View narrative
US$497.21
FV
27.2% overvalued
intrinsic discount
7.92%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
17 days ago
author updated this narrative